Health Care: Drugs

Medivation Inc (MDVN: NASDAQ)

$97.9 0.93 | 0.96%
10/22/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 96.97
52 Week High 103.88
52 Week Low 54.37
Avg. Daily Vol. (Mil) 1.17
Beta (3 year) -0.64
Share Related Items
Mkt Cap (Mil) 7,446.22
Shares Out (Mil) 76.79
Float (Mil) 64.53
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.50
Current Ratio 4.80
LT Debt/ Equity 1.62
Total Debt / Equity 1.62
Valuation Ratios
Price Earnings 349.90
Price/Sales 19.00
Price/Book 51.95
Price/Cash Flow 298.30
Per Share Data
Earnings 0.28
Sales 5.10
Book Value 1.87
Cash Flow 0.33
Business Summary
Medivation, Inc. is a biopharmaceutical company engaged in the development of novel small molecule drugs to treat diseases like Alzheimer's disease and Huntington disease.
General Information
36th Floor, 525 Market Stree
San Francisco, CA 94105
www.medivation.net
Industry : Drugs
Sector: Health Care
Employees: 433
CEO: Dr. David T. Hung,M.D.
Short Interest
Current Month (Mil) 3.37
Previous Month (Mil) 3.87
Short Interest Ratio (Days) 2.30
Management Effectiveness
Return on Equity 16.50
Return on Assets 4.90
Return on Investments 6.30
Profitability
Gross Margin n.a.
EBIT Margin 11.50
Profit Margin 6.00

Portfolios with MDVN

Latest MDVN Headlines from TheStreet

More Financial News for MDVN

Press Releases for MDVN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter